Preethi Sundaram
Chief Strategy Officer · CATALYST PHARMACEUTICALS, INC.
Individual
- 2024
- Jul 17, 2026
- 5
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Preethi Sundaram files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Elsbernd - $908K in CPRX purchases and sales in the last 12 months
- Molly Harper - $622K in CPRX purchases and sales in the last 12 months
- Carmen Jeffrey del - $256K in CPRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Preethi Sundaram?
Preethi Sundaram is a corporate insider, tracked as Chief Strategy Officer of CATALYST PHARMACEUTICALS, INC. (CPRX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Preethi Sundaram submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
